Paid Clinical Trials in Huntsville, AL
As of June 2026, 92 paid clinical trials are recruiting in Huntsville, Alabama. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Huntsville offers studies at sites including Clearview Cancer Institute for conditions such as Major Depressive Disorder, Migraine, Carcinoma, Non-Small-Cell Lung, Coronary Artery Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Huntsville
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Huntsville
Huntsville has approximately 92 recruiting research studies across a wide range of therapeutic areas. Alabama hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Huntsville
Researchers run research studies in Huntsville, AL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Clearview Cancer Institute | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Prostate Cancer | 9 |
| Huntsville Hospital | AAA, AAA - Abdominal Aortic Aneurysm, Acute Stroke | 6 |
| Heart Center Research LLC | Obesity, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease | 5 |
| Heart Center Research, LLC | Acute Myocardial Infarction, Heart Failure - NYHA II - IV, Heart Failure, Congestive | 4 |
| Apogee Clinical Research, LLC | Chronic Kidney Disease Requiring Chronic Dialysis, Diabetic Kidney Disease (DKD), End Stage Renal Disease on Dialysis | 3 |
| Nephrology Consultants, LLC | Atherosclerotic Cardiovascular Disease in Patients With ESKD, Proteinuric Kidney Disease, Proteinuric Kidney Diseases | 3 |
| Nutraceuticals Research Institute | Healthy Aging, Menopausal Hot Flashes, Menopausal Women | 3 |
| UAB Huntsville Regional Medical Campus | Major Depressive Disorder, Depression, Depression and Suicide | 3 |
| Apogee Clinical Research | Focal Segmental Glomerulosclerosis, Kidney Disease, Chronic | 2 |
| Heart Center Rsrch_Hunstville | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Heart Failure | 2 |
| Neurocrine Clinical Site | Major Depressive Disorder | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| AES - DRS - Optimal Research Alabama - Huntsville | Type II Diabetes Mellitus | 1 |
| Clearview Cancer Institute (Crestwood) | Cancer of the Prostate, Hormone Sensitive Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC) | 1 |
| Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621 | Colorectal Cancer | 1 |
| Heart Center Hospital | Mitral Regurgitation, Mitral Valve Insufficiency | 1 |
| Heart Center LLC, Huntsville | Aortic Stenosis, Calcific, Aortic Valve Stenosis | 1 |
| Heart Center Research | Cardiac Disease | 1 |
| HudsonAlpha Institute for Biotechnology, Inc. | Genetic Disease | 1 |
| Huntsville Heart Center | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 1 |
| Huntsville Hospital Heart Center | Cardiovascular Diseases | 1 |
| Huntsville, AL Investigative Site 10026 | Acute Heart Failure, Heart Failure | 1 |
| Local Institution - 0220 | Cancer | 1 |
| Longwood Research LLC | ASCVD, Type2Diabetes | 1 |
| Medical Affiliated Research Center | Clostridioides Difficile Associated Disease | 1 |
Active & Upcoming Studies in Huntsville (2026)
Recruiting trials in Huntsville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (15 active studies)
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure · Boston Scientific Corporation
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (13 active studies)
Cancer & tumors (12 active studies)
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract · Phase 3 · Eli Lilly and Company
- This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. · Phase 3 · Pfizer
Mental health & behavior (4 active studies)
- A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder · Phase 2 · AbbVie
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder · Phase 2 · AbbVie
Diabetes & metabolic (4 active studies)
HIV / STI (1 active study)
- Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention · University of Chicago
Common conditions studied in Huntsville
- Major Depressive Disorder (8 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Migraine (4 active studies). Migraine trials evaluate CGRP antagonists, gepants, and new acute and preventive therapies for chronic and episodic migraine.
- Carcinoma, Non-Small-Cell Lung (3 active studies). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Coronary Artery Disease (3 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
- Heart Failure (3 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Alzheimer Disease (2 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
Leading research sponsors in Huntsville
- AbbVie
- AstraZeneca
- Eli Lilly and Company
- Amgen
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in Alabama are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Alabama research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Huntsville. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Huntsville
Hipa.ai aggregates every recruiting study in Huntsville from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntsville?
There are approximately 92 recruiting clinical trials in Huntsville, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntsville pay participants?
Most recruiting trials in Huntsville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntsville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntsville?
The most common conditions under active study in Huntsville include Major Depressive Disorder (8), Migraine (4), Carcinoma, Non-Small-Cell Lung (3), Coronary Artery Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntsville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntsville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntsville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntsville?
Recruiting research sites in Huntsville include Clearview Cancer Institute, Huntsville Hospital, Heart Center Research LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntsville right now?
The largest active categories in Huntsville are Cardiovascular (15), Neurology & pain (13), Cancer & tumors (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.